Document Detail


Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
MedLine Citation:
PMID:  2145654     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep were compared in six patients with chronic obstructive lung disease and carbon dioxide retention. Patients received 1.5 mg/kg almitrine (a peripheral chemoreceptor stimulant), 100 mg of medroxyprogesterone (a central respiratory stimulant), or matched placebo daily for 15 days in random order in a crossover trial. When subjects were awake almitrine increased the ventilatory response to hypoxia and increased arterial oxygen tension (PaO2) to a greater extent than medroxyprogesterone, whereas medroxyprogesterone augmented the ventilatory response to hypercapnia and decreased arterial carbon dioxide tension (PaCO2) to a greater extent than almitrine. Neither drug influenced sleep architecture significantly, except that medroxyprogesterone increased the number of arousals. Almitrine had a more favourable effect than placebo on oxygenation as estimated from arterial oxygen saturation (SaO2) during the different stages of sleep, the number of episodes of hypoxaemia, and the amount of time that SaO2 was below 80%. The only change with medroxyprogesterone by comparison with placebo was a decrease in the number of hypoxaemic episodes. It is concluded that both active drugs improved blood gases during wakefulness, but that 1.5 mg/kg of almitrine is superior to 100 mg of medroxyprogesterone in improving SaO2 during sleep.
Authors:
E Daskalopoulou; D Patakas; V Tsara; F Zoglopitis; E Maniki
Related Documents :
20546724 - On the pulmonary toxicity of oxygen: iii. the induction of oxygen dependency by oxygen ...
20921084 - The effect of oxygenator mechanical characteristics on energy transfer during clinical ...
7468124 - Skeletal muscle oxygen pressure fields in artificially ventilated, critically ill patie...
21673614 - Comparison of 20-, 23-, and 25-gauge air infusion forces.
16380274 - Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving...
15119744 - Hypertensive encephalopathy mimicking brainstem tumour in psychiatric patient.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Thorax     Volume:  45     ISSN:  0040-6376     ISO Abbreviation:  Thorax     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-11-19     Completed Date:  1990-11-19     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  666-9     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Thessaloniki, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Almitrine / therapeutic use*
Carbon Dioxide / blood
Chemoreceptor Cells / drug effects
Humans
Lung Diseases, Obstructive / blood,  drug therapy*
Male
Medroxyprogesterone / analogs & derivatives*,  therapeutic use
Medroxyprogesterone Acetate
Middle Aged
Oxygen / blood*
Pulmonary Ventilation
Sleep / physiology*
Spirometry
Wakefulness / physiology
Chemical
Reg. No./Substance:
124-38-9/Carbon Dioxide; 27469-53-0/Almitrine; 520-85-4/Medroxyprogesterone; 71-58-9/Medroxyprogesterone Acetate; 7782-44-7/Oxygen
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acne and its drug treatment
Next Document:  Appropriate and inappropriate neuroendocrine products in pulmonary tumourlets.